What is the recommended treatment for gastritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gastritis Treatment

High-potency proton pump inhibitors (PPIs) such as esomeprazole 20-40 mg twice daily or rabeprazole 20 mg twice daily are the first-line treatment for gastritis, taken 30 minutes before meals for optimal effectiveness. 1, 2, 3

Initial Assessment

All patients with gastritis must be tested for H. pylori infection using non-invasive methods:

  • Urea breath test (UBT) or monoclonal stool antigen test are the recommended diagnostic approaches 1, 3
  • Avoid serological testing for confirming eradication as antibodies remain positive after successful treatment 3
  • If atrophic gastritis is present on histology, check antiparietal cell antibodies and anti-intrinsic factor antibodies to identify autoimmune etiology 3

Treatment Based on Etiology

H. pylori-Positive Gastritis

Bismuth quadruple therapy for 14 days is the preferred first-line treatment due to increasing clarithromycin and metronidazole resistance: 1, 2, 3

  • PPI (high-potency) + bismuth + metronidazole + tetracycline for 14 days 1, 3
  • Concomitant 4-drug therapy (PPI + amoxicillin + clarithromycin + metronidazole for 5-14 days) is an alternative when bismuth is unavailable, achieving ~90% eradication rates 1, 4
  • Sequential therapy (amoxicillin for 5 days, then clarithromycin + metronidazole for 5 days) shows similar efficacy to simultaneous administration 4

Higher-potency PPIs significantly improve H. pylori eradication rates: 1, 5

  • Esomeprazole 20-40 mg twice daily 1, 2
  • Rabeprazole 20 mg twice daily (equivalent to 36 mg omeprazole) 1
  • Lansoprazole 30 mg twice daily (equivalent to 27 mg omeprazole) 1
  • Avoid pantoprazole when possible - 40 mg pantoprazole equals only 9 mg omeprazole 1

Critical: Confirm eradication 4-6 weeks after completing therapy using non-serological testing (urea breath test or stool antigen test). 3

NSAID-Induced Gastritis

Discontinue NSAIDs immediately if possible. 2, 3

If NSAIDs must be continued:

  • Add high-potency PPI therapy for gastroprotection 1, 2
  • Use the lowest effective NSAID dose for the shortest duration 1, 2
  • Test and treat H. pylori before initiating long-term NSAID therapy, especially in patients with prior peptic ulcer history 1, 3

Misoprostol (synthetic PGE1) reduces NSAID-associated gastric ulcers by 74% and duodenal ulcers by 53%, but side effects (diarrhea, abdominal pain, nausea) limit its use. 1

Autoimmune Gastritis

Screen for nutritional deficiencies and associated autoimmune conditions:

  • Evaluate for vitamin B-12 and iron deficiencies in all patients 1, 3
  • Screen for concomitant autoimmune thyroid disease 1, 3
  • Consider surveillance endoscopy every 3 years for advanced atrophic gastritis 1, 3

H. pylori-Negative Gastritis or Post-Eradication Symptoms

For patients with residual symptoms after confirmed H. pylori eradication:

  • Full-dose PPI therapy (esomeprazole 20-40 mg twice daily or rabeprazole 20 mg twice daily) is first-line treatment 1
  • Antacids provide rapid, temporary relief for breakthrough symptoms and can be used on-demand 1, 2, 3
  • Gradual improvement with fluctuations is expected 1

PPI Dosing Optimization

PPIs must be taken 30 minutes before meals for maximum effectiveness - inadequate timing is a common pitfall that reduces efficacy. 1, 2

Recommended high-potency PPI regimens:

  • Rabeprazole: 20 mg twice daily 1, 2
  • Esomeprazole: 20-40 mg twice daily 1, 2
  • Lansoprazole: 30 mg twice daily 1, 2

Critical Pitfalls to Avoid

Antibiotic therapy duration: Never use less than 14 days for H. pylori eradication - shorter courses significantly reduce eradication rates 1, 2, 3

Confirmation of eradication: Relying solely on symptom resolution without confirming H. pylori eradication leads to persistent infection and complications 1, 3

PPI dosing errors: Inadequate PPI dosing and premature discontinuation are common mistakes 1, 2

Long-term PPI use in H. pylori-positive patients: This accelerates progression to corpus-predominant and atrophic gastritis - eradicate H. pylori first 1

Failure to evaluate nutritional deficiencies: In atrophic gastritis, not checking vitamin B-12 and iron levels leads to inadequate management 1, 3

References

Guideline

Gastritis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Gastritis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Gastritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Helicobacter pylori and gastric or duodenal ulcer.

Prescrire international, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.